Skip to main content

International Journal of Biological Macromolecules (2026): Is It a Good Journal?

IJBM JIF 8.7 is Elsevier's main venue for biopolymer research, proteins, polysaccharides, nucleic acids. Here's when your paper fits, what editors want, and how it compares to Carbohydrate Polymers and Biomacromolecules.

Editorial processThe Manusights editorial team researches and maintains these guides using source review, field-specific analysis, and our documented editorial process.How we work

Journal fit

See whether this paper looks realistic for International Journal of Biological Macromolecules.

Run the Free Readiness Scan with International Journal of Biological Macromolecules as your target journal and see whether this paper looks like a realistic submission.

Check my manuscript fitPrivate API processing. Your manuscript is not used to train models.See example reports
Journal context

International Journal of Biological Macromolecules at a glance

Key metrics to place the journal before deciding whether it fits your manuscript and career goals.

Full journal profile

What makes this journal worth targeting

  • International Journal of Biological Macromolecules's scope and readership determine whether the journal is a useful target.
  • Scope specificity matters more than headline metrics for most manuscript decisions.
  • Elsevier journal catalog reports an acceptance rate of 25% for International Journal of Biological Macromolecules. Journal-wide figure from Elsevier's journal catalog, read October 2026; the catalog does not state the reporting period or denominator, and the figure is not the odds for any one manuscript.

When to look elsewhere

  • When your paper sits at the edge of the journal's stated scope, borderline fit rarely improves after submission.
  • If timeline matters: International Journal of Biological Macromolecules takes ~5 days to first decision. A faster-turnaround journal may suit a grant or job deadline better.
  • If open access is required by your funder, verify the journal's OA agreements before submitting.
Quick verdict

How to read International Journal of Biological Macromolecules as a target

This page should help you decide whether International Journal of Biological Macromolecules belongs on the shortlist, not just whether it sounds impressive.

Question
Quick read
Best for
International Journal of Biological Macromolecules published by Elsevier covers protein science,.
Editors prioritize
Novel macromolecule with demonstrated biological function or therapeutic potential
Think twice if
Characterizing macromolecule structure without functional validation
Typical article types
Research Article, Short Communication, Review

Acceptance rate: Elsevier's journal catalog lists a 25% acceptance rate for International Journal of Biological Macromolecules (read October 2026). That is a journal-wide figure, not the odds for any one manuscript. Elsevier journal catalog.

Quick answer: Yes. International Journal of Biological Macromolecules (IJBM, JIF 8.7, 2026 JCR release) is a strong Q1 Elsevier journal for biopolymer research: proteins, polysaccharides and nucleic acids. It is a good journal for your paper only if the macromolecule is the subject, not an ingredient, and you can show both what it is and what it does.

Find your paper in the left column before you read anything else:

Your manuscript
IJBM verdict
Better first target
New polysaccharide or protein, structure tied to a measured activity
Strong fit
IJBM
Polysaccharide-only story with a big structural advance
Fits, but aim higher first
Carbohydrate Polymers
Chitosan, alginate or cellulose used as a coating, carrier or filler
Likely desk rejection
A biomaterials or drug-delivery journal
Biopolymer engineered for a device or material property
Weak fit
Biomacromolecules
Structure data with no function, or function with no structure
Desk-rejection risk
Finish the missing half first

The Core Editorial Question

IJBM editors care about one thing above all else: is the biological macromolecule the protagonist of this paper, or is it just an ingredient?

A paper that characterizes a novel polysaccharide's structure by NMR, demonstrates its conformation in solution, and connects that structure to a measurable biological activity is IJBM. A paper that uses chitosan as a coating on nanoparticles and measures drug release kinetics is not, that's a biomaterials paper wearing biopolymer language.

The distinction matters because IJBM receives enormous submission volume. Editors have gotten more aggressive about desk-rejecting papers where the macromolecule is peripheral.

Key Metrics

Metric
Value
2025 Journal Impact Factor (2026 JCR release)
8.7
5-Year IF
~8.0
Publisher
Elsevier
Quartile
Q1 in Biochemistry & Molecular Biology; Q1 in Polymer Science
Acceptance rate
25%
APC
$3,820 (OA option) or free (subscription)
Scope
Proteins, polysaccharides, nucleic acids, biological polymers
Review model
Single-blind

What Separates Papers That Get In From Papers That Don't

IJBM has a clear editorial line that many authors miss. The journal wants structure-function papers, not structure-only or function-only papers.

Papers editors want:

  • Protein characterization with direct functional evidence (binding, activity, folding behavior)
  • Polysaccharide structure elucidation connected to biological or physical properties
  • Nucleic acid work where the macromolecular behavior drives the science
  • Biopolymer modification studies that measure functional consequences, not just confirm the modification happened
  • Interaction studies (protein-protein, protein-polysaccharide, biopolymer-drug) with mechanistic explanation

Papers that get desk-rejected:

  • Gene or genome analysis without direct macromolecular structure-function evidence
  • Application papers where the biopolymer is a passive ingredient (coatings, fillers, matrices)
  • Characterization-only work that confirms structure but never explains function
  • Clinical or biomedical studies where the macromolecule is not the active scientific core
  • Papers below the molecular size floor (small molecules, peptides under ~2 kDa)

How IJBM Compares

Journal
IF (2025)
Publisher
Best For
Carbohydrate Polymers
13.2
Elsevier
Carbohydrate-based polymers specifically
IJBM
8.7
Elsevier
All biological macromolecules, proteins, polysaccharides, nucleic acids
Biomacromolecules
5.9
ACS
Biomacromolecular materials and engineering
Polymer
5.1
Elsevier
Broader polymer science including synthetic polymers

For protein work, nucleic acid work, or mixed biopolymer systems, Carbohydrate Polymers isn't an option and IJBM is the natural first choice.

The Biomacromolecules comparison: Biomacromolecules (JIF 5.9, ACS) publishes at the interface of biology and materials science. If your paper is about engineering a biopolymer for a materials application, Biomacromolecules may be the better fit. If the story is about understanding the macromolecule itself (its structure, function, and behavior) IJBM is stronger.

The Polymer comparison: Polymer (JIF 5.1, Elsevier) covers synthetic and natural polymers broadly. IJBM wins when the biological identity of the macromolecule matters to the science, not just its polymer properties.

Submit if

  • The biological macromolecule is genuinely the center of the paper from title to conclusion
  • You have both structural characterization AND functional/biological evidence
  • The paper teaches something about why the macromolecule behaves the way it does
  • Your biopolymer isn't just a carbohydrate (otherwise, try Carbohydrate Polymers first)

Journal fit

See whether this paper looks realistic for International Journal of Biological Macromolecules.

Run the scan with International Journal of Biological Macromolecules as the target. Get a manuscript-specific fit signal before you commit.

Check my manuscript fitPrivate API processing. Your manuscript is not used to train models.See example reports

Think twice if

  • The macromolecule is really just a component in a formulation, device, or delivery system
  • You have structure data but no functional evidence, or functional data but no structure
  • The real contribution is to food science, biomaterials, or drug delivery rather than macromolecular science
  • A more specialized journal (Proteins, Nucleic Acids Research, Food Hydrocolloids) would give the paper a more engaged readership

The Volume Question

IJBM publishes over 2,000 papers per year. Some researchers see this as a warning sign, high-volume journals sometimes dilute quality. In IJBM's case, the volume reflects the enormous breadth of biopolymer research worldwide rather than low standards. But the sheer volume means that individual papers can get less attention than they would in a smaller journal.

If citation visibility matters more to you than journal prestige, consider whether a more specialized venue would put your paper in front of a more targeted readership.

What we would fix before an IJBM submission

In our pre-submission review work on biopolymer manuscripts, three IJBM patterns come up often enough that we check for them first. None of them needs a new project. Each needs one analysis, one figure or one honest sentence.

The extraction paper that stops at yield. A polysaccharide is isolated from a plant, the monosaccharide composition and FTIR spectrum fill the first figures, an antioxidant assay fills the last, and the discussion never links a structural feature (branching, molecular weight, sulfation, chain conformation) to the activity it measured. An International Journal of Biological Macromolecules editor reads that as characterization plus an assay. Fractionate by molecular weight and show that activity tracks a structural variable, or modify one feature and show the activity moves.

The coating paper with a macromolecule in the title. Chitosan, alginate or cellulose appears in the title and abstract, but every result is about release kinetics, tensile strength or shelf life. Strip the application framing from the methods and results: if nothing about the biological macromolecules themselves is left to discuss, IJBM is the wrong journal and a materials or food-packaging title will read the paper more kindly.

The protein study with no control for the modification. A protein is glycated, crosslinked or conjugated, and the results report the new function without showing the unmodified protein under the same conditions. For International Journal of Biological Macromolecules, the comparison table against the native macromolecule is what turns a description into structure-function evidence, so put it in the main text, not the supplementary file.

If you cannot fix the pattern that applies, say so plainly in the limitations and pick the venue that fits the paper you have.

A good IJBM paper is also not automatically a strong line on every CV. Promotion committees in biochemistry and food science read it as a solid Q1 venue; panels in molecular or biomedical biology often weigh it below the society journals of their own field, so check what your committee counts before you choose it over a narrower title.

The Structure-Function Test

Before submitting to IJBM, run this test: remove all application framing from your paper. Does the macromolecule itself remain scientifically interesting? If yes, IJBM is likely a good fit. If the paper becomes empty without the application context, the macromolecule isn't really the protagonist and another journal is the better choice.

A IJBM scope and readiness check can help assess whether the structure-function case is strong enough for IJBM before you submit.

Before you submit

Because IJBM handles such high submission volume, its editors desk-reject quickly on a single question: is the macromolecule the protagonist? The framing failures that trigger rejection are predictable. A biopolymer used as a passive coating or filler, a paper with structure data but no functional evidence (or the reverse), and a study where the real contribution is to food science or drug delivery rather than macromolecular science all read as off-scope. Fixing the framing, or honestly redirecting the paper, is far cheaper before submission than after.

A IJBM submission readiness check identifies the specific framing and scope issues that trigger desk rejection before you submit.

Why timing your submission matters

Journal editorial capacity fluctuates. Submissions during major conference seasons face longer reviewer turnaround. End-of-year submissions may sit longer during holiday periods. New IF announcements (June each year) can temporarily increase submissions to journals whose IF rose.

For selective journals, the practical advice is: submit when the manuscript is ready, not when the calendar seems favorable. A paper that is scientifically complete and properly targeted will succeed regardless of timing. A paper with gaps will fail regardless of when you submit.

A IJBM submission readiness check evaluates fit independently of timing.

How to use this information strategically

Use the structure-function test as your first filter, then pick the venue. If the macromolecule stays scientifically interesting once you strip the application framing, IJBM is a strong fit. If your biopolymer is specifically a polysaccharide, Carbohydrate Polymers is the higher-impact target worth trying first. If the work is really about engineering a biopolymer for a materials application, Biomacromolecules is more honest, and a structure-function paper on a protein or nucleic acid points squarely back to IJBM. Settling the venue before you write the cover letter avoids a fast desk rejection at the wrong journal.

A IJBM scope and readiness check gives you the verdict: does your paper fit this journal?

Frequently asked questions

International Journal of Biological Macromolecules has a 2025 Journal Impact Factor of 8.7 and a 5-year IF of approximately 8.0. It is ranked Q1 in both Biochemistry & Molecular Biology and Polymer Science by Clarivate.

IJBM publishes research on biological macromolecules, proteins, polysaccharides, nucleic acids, and other biopolymers. The key requirement is that the macromolecule itself must be the scientific center of the paper. Characterization of structure AND function is expected, not just one or the other.

Carbohydrate Polymers (JIF 13.2, Elsevier) has a higher IF but narrower scope, carbohydrate-based polymers only. If your biopolymer is a polysaccharide, Carbohydrate Polymers is the more prestigious target. If it's a protein, nucleic acid, or mixed biopolymer system, IJBM is the natural home.

In biopolymer, biochemistry, and food science departments, IJBM at IF 8.7 is a strong Q1 publication. It carries real weight for tenure and promotion in these fields. At departments focused on pure molecular biology or biomedical sciences, reviewers may look for journals with stronger biological emphasis like JBC or EMBO Journal.

References

Sources

  1. IJBM journal homepage, Elsevier.
  2. IJBM guide for authors, Elsevier.
  3. Clarivate Journal Citation Reports (2026 JCR release for the 2025 Journal Impact Factor).

Free guide

A ranked list cannot tell you where your own paper belongs.

The guide runs the last-ten-papers test, which is reading what a journal has actually published recently and asking whether your paper would sit comfortably beside it. Then you score each candidate 0 to 2 on fit, and let impact factor break ties rather than start the decision.

The guide, plus the weekly brief on getting published. One email on Mondays, unsubscribe in one click.

Final step

See whether this paper fits International Journal of Biological Macromolecules.

Run the Free Readiness Scan with International Journal of Biological Macromolecules as your target journal and get a manuscript-specific fit signal before you commit.

Target journal International Journal of Biological Macromolecules

Check my manuscript fit

Private API processing. Your manuscript is not used to train models.

See example reports

Put the guidance to work

Build a journal decision from more than one signal.

Use comparison data as a starting point, then confirm the live source that governs the actual submission decision.

Internal navigation

Where to go next